MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Antiviral activity of a bile pigment, biliverdin, against human herpesvirus 6 (HHV-6) in vitro.
Antiviral activity of a zymolytic grain based extract on human immunodeficiency virus type 1 in vitro.
Circularization of human immunodeficiency virus type 1 DNA in vitro.
Integration of human immunodeficiency virus type 1 DNA in vitro.
Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.
Morphogenesis of human immunodeficiency virus type 1.
Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro.
Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.
Inhibition of proliferation of human immunodeficiency virus type 1 by novel heteropolyoxotungstates in vitro.
L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro.
In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.
Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro.
Decreased accessory cell function of macrophages after infection with human immunodeficiency virus type 1 in vitro.
In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription.
Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees.
Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro.
CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro.
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.
5-azacytidine and 5-azadeoxycytidine inhibit human immunodeficiency virus type 1 replication in vitro.
Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.
Antifusion activity in sera from persons infected with human immunodeficiency virus type 1.
A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators.
Human immunodeficiency virus type 1 nef quasispecies in pathological tissue.
In vitro anti-human immunodeficiency virus type 1 activity of biliverdin, a bile pigment.
Biliverdin (BV) is a bile pigment having anti-allergic properties. We examined the effect of BV on human immunodeficiency virus type 1 (HIV-1) in vitr...
133KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Antiviral activity of a bile pigment, biliverdin, against human herpesvirus 6 (HHV-6) in vitro.
Antiviral activity of a zymolytic grain based extract on human immunodeficiency virus type 1 in vitro.
Circularization of human immunodeficiency virus type 1 DNA in vitro.
Integration of human immunodeficiency virus type 1 DNA in vitro.
Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.
Morphogenesis of human immunodeficiency virus type 1.
Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro.
Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.
Inhibition of proliferation of human immunodeficiency virus type 1 by novel heteropolyoxotungstates in vitro.
L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
